Biotech News
Mdxhealth to Release First Quarter 2025 Financial Results on May 14
Company to Host Conference Call with Live Q&A, May 14, 2025, at 4:30pm ET / 22:30 CET
IRVINE, California – April 30, 2025 ( GlobeNewswire ) – MDxHealth SA (NASDAQ: MDXH), a leading precision diagnostics company, today announced it will release its financial results for the first quarter ended March 31, 2025, after market close on Wednesday, May 14, 2025.
| Title: | Mdxhealth Presents First Quarter 2025 Financial Results and Corporate Update Conference Call and Webcast |
|---|---|
| Speakers: | Michael K. McGarrity, Chief Executive Officer Ron Kalfus, Chief Financial Officer |
| Date: | May 14, 2025 |
| Time: | 4:30pm ET/ 22:30 CET |
| Conference Call D ial-in Details: | United States: 1-844-825-9789 Belgium: 0800 38 961 The Netherlands: 0800 94 94 506 United Kingdom: 0808 238 9064 |
| Conference ID: | 10199102 |
| Webcast: | https://viavid.webcasts.com/starthere.jsp?ei=1716341&tp_key=092e4b795e |
The webcast should be accessed 15 minutes prior to the conference call start time. A replay of the webcast will be available following the conclusion of the live call and will be accessible on the Company’s website.
About Mdxhealth
Mdxhealth is a leading precision diagnostics company that provides actionable molecular information to personalize patient diagnosis and treatment. The Company’s tests are based on proprietary genomic, epigenetic (methylation) and other molecular technologies and assist physicians with the diagnosis and prognosis of urologic cancers and other urologic diseases. The Company’s U.S. headquarters and laboratory operations are in Irvine, California, with additional laboratory operations in Plano, Texas. European headquarters are in Herstal, Belgium. For more information, visit mdxhealth.com and follow us on social media at: twitter.com/mdxhealth, facebook.com/mdxhealth and linkedin.com/company/mdxhealth.